BIOMAT Database Logo BIOMAT Database Logo

Cytosine arabinoside administered intrathecally in cerebromeningeal leukemia. 1970

B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis

Related Publications

B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
Cytosine arabinoside in acute granulocytic leukemia.
January 1971, Clinical pharmacology and therapeutics,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
January 1974, Bulletin du cancer,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
Cytosine arabinoside in acute leukemia of childhood.
October 1971, Cancer,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
Bone marrow stromal dysfunction in mice administered cytosine arabinoside.
April 2001, European journal of haematology,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
[The use of cytosine arabinoside in children. III. Cytosine arabinoside in chickenpox during acute lymphoblastic leukemia].
November 1975, Minerva pediatrica,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia.
June 1977, Clinical pharmacology and therapeutics,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
[Cytosine arabinoside in the polychemotherapy of acute leukemia].
March 1972, Minerva medica,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.
January 1980, Cancer,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
Cytosine arabinoside (NSC-63878) in acute leukemia in children.
July 1966, Cancer chemotherapy reports,
B Halikowski, and R Cyklis, and J Armata, and S Garwicz, and J Wyszkowski, and M Garapich
Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.
August 1973, Cancer,
Copied contents to your clipboard!